-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – AVX-901 in Metastatic Breast Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AVX-901 in Metastatic Breast Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AVX-901 in Metastatic Breast Cancer Drug Details: AVX-901 (HER2 VRP vaccine)...
-
Company Profile
Acushnet Holdings Corp – Company Profile
Acushnet Holdings Corp (Acushnet), a subsidiary of FILA Holdings Corp, manufactures, designs, develops, and distributes golf products. The company’s product portfolio includes golf gloves, golf gear, wedges, putters, golf wears, golf balls, golf bags, headwear, travel gear, accessories, golf gloves, golf shoes, socks, outerwear, and apparel. Acushnet markets these products under Titleist, Pro V1, Pro V1x, AVX, FJ, FootJoy, T Series, Vokey Design, KJUS, Scotty Cameron and Pinnacle brand names. It sells the products through golf specialty retailers, on-course golf...
Add to Basket -
Thematic Analysis
Electric Aircraft – Thematic Intelligence
Electric Aircraft Report Overview Technological advances in batteries, electric motors, and lightweight composite materials in recent years have made the development of electric aircraft increasingly viable, and in many cases a reality. Lithium-ion batteries can offer a great enough specific energy to allow electric aircraft to compete with conventionally powered aircraft in many sectors. The benefits and applications of electric aircraft are diverse, ranging from cleaner commercial aviation to air taxis, high-speed broadband enablers, and even space launch systems. With...
-
Product Insights
AVX Corp – Fountain Inn Manufacturing Facility Expansion – South Carolina
Equip yourself with the essential tools needed to make informed and profitable decisions with our AVX Corp - Fountain Inn Manufacturing Facility Expansion - South Carolina report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive...
-
Company Profile
Kyocera AVX Components Corp – Company Profile
Kyocera AVX Components Corp (AVX), is a manufacturer, marketer, and reseller of electronic components, sensing devices, interconnects, control devices, and related products. The company’s product portfolio comprises thermistors, radio frequency and microwave components, capacitors, resistors, inductors, filters, diodes, custom thin film passives, connectors, circuit protection and broadband components. It serves to telecommunications, computer, transportation, automotive, energy harvesting, medical, military, aerospace, instrumentation and consumer electronics industries. The company caters through independent electronic component distributors, direct sales personnel, independent manufacturers’ representatives, and...
Add to Basket -
Company Profile
Novartis Gene Therapies – Company Profile
Novartis Gene Therapies, formerly AveXis Inc, is a biotechnology company. It operates as a subsidiary of Novartis AG. The company develops treatments for rare and potentially fatal neurological genetic diseases. The company’s product, Zolgensm is a proprietary gene therapy candidate for pediatric patients for the treatment of spinal muscular atrophy. It is also pursuing gene therapies for Rett syndrome (AVXS-201), and a genetic form of amyotrophic lateral sclerosis (ALS) caused by mutations in the superoxide dismutase 1 (SOD1) gene (AVXS-301)....
Add to Basket -
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – AVX-101
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry AVX-101 Drug Details AVX-101 (Alphavirus Replicon HIV-1 Subtype C Gag Vaccine) is under development...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – AVX-901
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry AVX-901 Drug Details AVX-901 (HER2 VRP vaccine) is under development for the treatment of...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – AVX-601
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry AVX-601 Drug Details AVX-601 is under development against of viral infections caused by cytomegalovirus....
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – AVX-502
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry AVX-502 Drug Details AVX-502 is under development for the prevention of H3N2 seasonal influenza...